|
Q4 FY2025
As of Dec 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
Q4 FY2017
As of Dec 31, 2017
|
|
|---|---|---|---|---|---|---|---|---|---|
| Current assets: | |||||||||
| Cash and cash equivalents | |||||||||
| Restricted deposit | |||||||||
| Trade receivables, net | |||||||||
| Inventories | |||||||||
| Other accounts receivable and prepaid expenses | |||||||||
| Total current assets | |||||||||
| Non-current assets: | |||||||||
| Restricted deposit | |||||||||
| Operating lease right-of-use assets | |||||||||
| Property and equipment, net | |||||||||
| Intangible assets, net | |||||||||
| Total non-current assets | |||||||||
| Total assets | |||||||||
| Current liabilities: | |||||||||
| Trade payables | |||||||||
| Operating lease liabilities | |||||||||
| Accrued liabilities and other payables | |||||||||
| Total current liabilities | |||||||||
| Non-current liabilities: | |||||||||
| Operating lease liabilities | |||||||||
| Total non-current liabilities | |||||||||
| Total liabilities | |||||||||
| Shareholders’ Equity: | |||||||||
| Ordinary shares, NIS 1.5 par value - authorized: 30,000,000 ordinary shares as of December 31, 2025 and 2024; issued and outstanding: 12,803,006 and 11,454,512 ordinary shares as of December 31, 2025 and 2024, respectively | |||||||||
| Additional paid in capital | |||||||||
| Accumulated other comprehensive loss | |||||||||
| Accumulated deficit | |||||||||
| Total shareholders’ equity | |||||||||
| Total liabilities and shareholders’ equity | |||||||||
Loading...
